Skip to main content
Premium Trial:

Request an Annual Quote

Metabolon Raises Additional $15M in Financing

NEW YORK (GenomeWeb) – Metabolon said today that it has raised an additional $15 million in funding from healthcare equity firm Essex Woodlands.

Essex Woodlands invested an initial $15 million in Metabolon in August.  At the time, the company said it planned to use  the money to develop and commercialize its pipeline of metabolomics technology-based precision medicine products. Metabolon also noted that Essex had the option to increase its investment by an additional $10 million, which would be used to repurchase shares from existing investors. 

Indeed, Metabolon said that the funds from Essex’s follow-on investment have already been used to repurchase and retire certain shares held by existing investors.

Including this latest investment, Metabolon has raised approximately $95 million in funding since it was founded in 2000.

The Scan

Call for a Different Tack

Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News.

Wastewater Warning

The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge.

Can't Get in the Program

Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports.

Science Paper on Spatial-Controlled Genome Editing

In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.